NRG
54
2
D
48
2
EFX
41
-2
GOOGL
48
5
SYF
62
5
C
71
3
STI
24
4
ZTS
16
-7
SEE
42
-2
MAC
47
3
AN
49
5
HD
25
-12
BBY
36
-4
PRGO
35
2
CA
9
-12
APH
74
13
TSCO
49
-6
CF
51
-5
EW
25
2
FTI
64
-2
NRG
54
2
D
48
2
EFX
41
-2
GOOGL
48
5
SYF
62
5
C
71
3
STI
24
4
ZTS
16
-7
SEE
42
-2
MAC
47
3
AN
49
5
HD
25
-12
BBY
36
-4
PRGO
35
2
CA
9
-12
APH
74
13
TSCO
49
-6
CF
51
-5
EW
25
2
FTI
64
-2
Financhill
Back

NeuroPace Stock Price Chart

Notable investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
30

NPCE
NeuroPace

Last Price:
$10.41
Seasonality Move:
31.16%

7 Day Trial

ALL ACCESS PASS

$ 7

How to hack a $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NPCE is experiencing slight selling pressure.

NeuroPace Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 11.56 Sell
20-day SMA: 13.19 Sell
50-day SMA: 12.72 Sell
200-day SMA: 10.75 Sell
8-day EMA: 11.48 Sell
20-day EMA: 12.51 Sell
50-day EMA: 12.8 Sell
200-day EMA: 11.44 Sell

NeuroPace Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.76 Sell
Relative Strength Index (14 RSI): 32.47 Sell
Chaikin Money Flow: -85903 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.45 - 16.47) Sell
Bollinger Bands (100): (10.91 - 14.47) Sell

NeuroPace Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for NeuroPace Stock

Is NeuroPace Stock a Buy?

  • NeuroPace share price is 10.60 while NPCE 8-day simple moving average is 11.56, which is a Sell signal.
  • The stock price of NPCE is 10.60 while NeuroPace 20-day SMA is 13.19, which makes it a Sell.
  • NeuroPace 50-day simple moving average is 12.72 while NPCE share price is 10.60, making it a Sell technically.
  • NPCE stock price is 10.60 and NeuroPace 200-day simple moving average is 10.75, creating a Sell signal.

NPCE Technical Analysis vs Fundamental Analysis

Sell
30
NeuroPace (NPCE) is a Sell

Is NeuroPace a Buy or a Sell?

  • NeuroPace stock is rated a Sell
    The current NeuroPace [NPCE] share price is $10.60. The Score for NPCE is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.

NeuroPace Stock Info

Market Cap:
347.7M
Price in USD:
10.60
Share Volume:
237.8K

NeuroPace 52-Week Range

52-Week High:
18.98
52-Week Low:
5.45
Sell
30
NeuroPace (NPCE) is a Sell

NeuroPace Share Price Forecast

  • What is the NeuroPace stock price today?
    The NeuroPace stock price is 10.60 USD today.
  • Will NPCE stock go up or go down?
    NeuroPace> share price is forecast to RISE/FALL based on technical indicators
  • Is NeuroPace overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, NeuroPace is overvalued.

Is NeuroPace Stock a Buy?

  • NeuroPace share price is 10.60 while NPCE 8-day exponential moving average is 11.48, which is a Sell signal.
  • The stock price of NPCE is 10.60 while NeuroPace 20-day EMA is 12.51, which makes it a Sell.
  • NeuroPace 50-day exponential moving average is 12.80 while NPCE share price is 10.60, making it a Sell technically.
  • NPCE stock price is 10.60 and NeuroPace 200-day simple moving average is 11.44, creating a Sell signal.

Fundamental Analysis of NeuroPace

Is NeuroPace a good investment?

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.05 per share, an increase this year of $0.17 per share, and an increase next year of $0.22 per share.

Technical Analysis of NeuroPace

Should I short NeuroPace stock?

  • NPCE Moving Average Covergence Divergence (MACD) indicator is -0.76, suggesting NeuroPace is a Sell
  • NeuroPace Relative Strength Index (RSI) is 32.47, which suggest NeuroPace is oversold
  • The Bollinger Bands (25) for NeuroPace is (11.45 - 16.47), which suggest NeuroPace is a Sell
  • The Bollinger Bands (100) for NeuroPace is (10.91 - 14.47), which suggest NeuroPace is a Sell

* NeuroPace stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.